Answers · Invention & Disclosures
What criteria should a patent review committee use to triage disclosures?
Updated June 2026
The short answer
Score every disclosure against five criteria: alignment with the business and product roadmap, detectability of infringement, competitive value, breadth beyond a single implementation, and cost across the patent's life. Then route it to one of four outcomes: file, hold for re-review, protect as a trade secret, or publish defensively. A 20 to 40 percent disclosure-to-filing conversion rate is a commonly cited band for a healthy pipeline.
The committee's job is allocation rather than grading. Filing budgets are finite and every yes crowds out another filing, so the criteria exist to make the trade-offs explicit and repeatable.
Five triage criteria and the question each asks
| Criterion | The question the committee asks |
|---|---|
| Business alignment | Does this protect a product, roadmap commitment, or licensing opportunity we actually have? |
| Detectability | Could we tell from a competitor's product that it infringes? |
| Competitive value | Would a competitor want this, and how easily could they design around it? |
| Breadth | Does the disclosure support claims beyond a single implementation? |
| Lifecycle cost | Is this worth a multi-year commitment of drafting, prosecution, and maintenance budget? |
The five criteria in practice
Business alignment asks whether the invention protects a product you ship, a roadmap direction you are committed to, or a licensing opportunity you would actually pursue. Patents disconnected from the business become maintenance-fee liabilities. Detectability asks whether you could tell from the outside that a competitor's product infringes. An invention you cannot detect is hard to enforce, and patenting it publishes the recipe; those candidates often belong in the trade secret lane instead. Competitive value asks whether a competitor would want the invention and how hard the design-around is: a patent with an easy work-around buys little even when the invention is clever.
Breadth asks whether the disclosure supports claims beyond one embodiment. Thin single-implementation disclosures produce narrow patents, and the better response is sending them back for strengthening rather than filing weak. Lifecycle cost treats every filing as the multi-year commitment it is: drafting, prosecution, issue and maintenance fees, and any foreign filings. Our patent budget calculator puts planning numbers on that commitment.
The four outcomes and what each requires
File means assigning counsel, a priority level, and a jurisdiction strategy, with patentability judgment belonging to your attorney or agent. Hold means a named re-review date, not a euphemism for never; markets move, and last year's marginal disclosure can become this year's must-file. Trade secret means routing the invention into an actual protection program, with access controls and documentation, since deciding not to file protects nothing by itself. Defensive publication means publishing the invention so competitors cannot patent it, a low-cost option when your main interest is freedom to operate rather than exclusivity.
Every decision goes back to the inventor with the reason. The feedback loop is what keeps next quarter's disclosures coming, and committees that skip it slowly starve their own pipeline.
Committee mechanics that keep it working
A working committee is small: IP counsel (in-house or outside), a technical lead per business area, and a business or product owner. It meets monthly at any real volume, quarterly at minimum, and decides within weeks of submission. Each disclosure gets a one-page scorecard against the five criteria, prepared before the meeting, and a time-boxed discussion. The clean division of authority: counsel judges patentability and legal risk, the business judges whether the filing is worth the money. ipCapital Group sits on the business side of that line; we are a consultancy, not a law firm.
Calibrate against your conversion rate over time. Sustained conversion far outside the commonly cited 20 to 40 percent band is a prompt to examine either capture quality or committee behavior, and we cover that diagnosis in a separate answer linked below.
Related questions
Who has the final say, counsel or the business?
Split it cleanly. Counsel owns patentability, inventorship, and legal risk. The business owns whether the filing is worth the budget. Most committee dysfunction traces to one side making the other's call.
Should inventors present to the committee?
A brief Q&A helps on borderline disclosures, and meeting the committee humanizes the process. Avoid making inventors defend their work in an adversarial format; the scorecard should carry the case, with the inventor available for questions.
How many disclosures can one meeting handle?
With scorecards prepared in advance, a disciplined committee gets through 10 to 20 in a session. Without preparation, three disclosures can eat an hour each. The scorecard is what makes monthly cadence sustainable.
What about a strong invention outside our core business?
That is a monetization question rather than a triage failure. Inventions with value to someone else can be licensed or sold, and that lane deserves an explicit owner. Our monetization practice exists for exactly that inventory.
Put a scorecard behind every filing decision
We help committees build triage criteria tied to business value, and we can stress-test yours against 25 years of engagement experience. The discovery call is free.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.